Marc Scheineson is quoted on a new Food and Drug Administration proposal for over-the-counter drug therapies.
In the News
November 30, 2022
HBW Insight | Will ACNU Proposal’s Dual Rx/OTC Component Simultaneously Help and Hinder Switches?
Media Contact